Oman Medical Devices Market Size, Share & Forecast, By Product Type, Care Setting & End User, 2025-2032

Expansion of Hospital Infrastructure and Installed Clinical Capacity

• Existing public infrastructure included 50 hospitals and more than 5,000 beds (2023, Oman), creating replacement, maintenance and consumables demand alongside greenfield procurement.
• Samail Hospital adds 170 beds (project specification, Oman), supporting new demand for operating-room, critical-care, sterilization, imaging and bedside-monitoring systems.
• Al Falah Hospital is designed with 170 beds and 38 outpatient clinics (project specification, Oman), widening addressable procurement for OEMs and service providers in South Al Sharqiyah.

Rising Chronic Disease Diagnostic and Monitoring Intensity

• More than 2,000 new cancer cases annually (2025, Oman) reinforce demand for imaging, pathology, biopsy, infusion-support and image-guided intervention technologies.
• Approximately one in three individuals has high blood pressure (2025, Oman), supporting recurring blood-pressure monitoring, cardiovascular diagnostics and chronic-care device demand.
• Overweight or obesity affects 66% of the population (2025, Oman), increasing long-term diagnostic intensity and expanding the addressable installed base for metabolic and cardiovascular monitoring technologies.

Private Healthcare Expansion and Quality Formalization

• Initial approvals also covered 215 private health institutions (referenced 2024 cycle, Oman), increasing the number of potential diagnostic, monitoring and treatment-device buyers.
• Private healthcare serves approximately 2 million expatriate beneficiaries (2024, Oman), giving private operators a large recurring patient base for diagnostics and specialist procedures.
• Approximately 37 private health institutions participated in the Aman patient-safety initiative (2024, Oman), increasing emphasis on device quality, traceability and clinical-risk controls.

High Dependence on Imported Devices and Components

High Dependence on Imported Devices and manufacturers, with USD 80.3 million of HS 9018 imports (2024, Oman) alone.

• The HS 9018 category excludes several major device pools, meaning USD 80.3 million (2024, Oman) represents only part of total import exposure and understates broader dependency.
• HS 9018 imports were around USD 89 million in 2022 (Oman) before declining in 2023, illustrating year-to-year volatility that can affect distributor inventory and working capital.
• Import-led distribution requires local inventory resilience because government medical-supply operations serve a national network including regional warehouses in Nizwa and Salalah, increasing fulfillment complexity outside Muscat.

More Formal Regulatory and Market-Access Requirements

• Manufacturer registration also requires approximately 60 working days (2025, Oman), making regulatory sequencing material to distributor appointment, launch timing and tender eligibility.
• Oman's Drug Safety Center maintained dedicated medical-device circulars across 2025 and 2026, indicating increasingly active post-market, establishment and registration oversight.
• A 2026 circular linked medical-device establishment approval with clearance services, increasing the operational cost of weak local compliance and favoring established channel partners.

Small National Scale and Concentrated High-Acuity Demand

• Qatar's health expenditure was approximately USD 1,804 per capita (2023, Qatar), illustrating the higher spending intensity available to device suppliers in some neighboring GCC markets.
• Saudi Arabia's health expenditure was approximately USD 1,825 per capita (2023, Saudi Arabia), reinforcing the scale disadvantage faced by suppliers pursuing Oman-only commercial models.
• Oman's public system included 50 Ministry of Health hospitals at end-2023, concentrating major capital-equipment opportunities into a relatively finite institutional-account universe.

CEPA-Enabled Sourcing and Supplier Portfolio Reconfiguration

• The agreement covers 99.38% of Indian export value (2026, India-Oman), creating a monetizable opportunity for distributors to add cost-competitive devices, components and consumables to Oman portfolios.
• CEPA entered into force on 1 June 2026, giving OEMs and distributors a defined timetable for repricing sourcing strategies and tender bids.
• Bilateral trade reached USD 11.18 billion in FY2025-26, supporting logistics density and commercial connectivity that medical-device suppliers can leverage for faster regional replenishment.

Connected Equipment and Lifecycle-Service Revenue

• Oman International Hospital occupies approximately 42,000 square meters, providing a reference environment for monetizing imaging, digital workflow, clinical engineering and lifecycle support.
• The partnership structure spans 10 years, demonstrating how suppliers can shift from one-time equipment sales toward recurring service, training and technology-upgrade revenue.
• Oman's quality-assurance framework added a national clinical-risk guideline in March 2025, strengthening the business case for connected asset monitoring, preventive maintenance and traceable device performance.

Local Technical Service, Warehousing and Regulatory Support Hubs

• Oman's Directorate General of Medical Supplies operates regional warehousing infrastructure in locations including Nizwa and Salalah, showing the strategic importance of distributed inventory and service coverage.
• Government supply operations cover surgical and laboratory items across Ministry of Health institutions, creating recurring opportunities in quality-assured consumables, stock management and technical support.
• A 2026 establishment-clearance linkage raises the value of locally capable regulatory and distribution partners that can manage product approval, clearance, inventory and field-service requirements together.